Inventor · disambiguated record
Angela Mennicke Lopez-Gitlitz
Also filed as: LOPEZ-GITLITZ ANGELA · LOPEZ-GITLITZ ANGELA MENNICKE
0 granted patents·5 pending applications·0 citations·filing 2021–2023
Files withJANSSEN PHARMACEUTICA NV5
Top patents by PatentIndex Score
5 records- 0160US2023226080A1Treatments of prostate cancer with combinations of abiraterone acetate and niraparibJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0260US2023226081A1Pharmaceutical formulations of abiraterone acetate and niraparibJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0360US2023218640A1Treatment of prostate cancer with a combination of abiraterone acetate and niraparibJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0454US2025170146A1Niraparib and abiraterone acetate plus prednisone to improve clinical outcomes in patients with metastatic castration-resistant prostate cancer and hrr alterationsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 0554US2024325369A1Treatment of metastatic castration-resistant prostate cancer with niraparibJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Angela Mennicke Lopez-Gitlitz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →